SourcingAI
Try for free
Powered by Made-in-China.com
Raw Material Factory Supply High Quality API Mifepristone CAS#84371-65-3
US$800.00-1,000.00
1 kg
Sample price:US$300.00/gram.Request sample

Product profile

Customization

Available

Powder

No

Customized

Non-Customized

Model NO.

CAS#84371-65-3

Certification

GMP, HSE, ISO 9001, USP, BP

Suitable for

Elderly, Children, Adult

State

Solid

Purity

>99%

Transport Package

25kg/Drum

Specification

42*42*52

Trademark

Hanways

Origin

China

HS Code

29372900

Production Capacity

2000 Kilogram/Month

Key features

High Purity Assay: Assay guaranteed to be greater than 99% for consistent quality.
GMP Certification: Manufactured under Good Manufacturing Practice standards.
Custom Synthesis Available: Custom synthesis services are offered for specific requirements.
Flexible MOQ: Minimum order quantity starts at just 1kg.
Global Shipping Options: Available via FOB, CFR, CIF, CIP, and CPT terms.
Fast Lead Time: Peak and off-peak season lead times are within 15 workdays.
Multiple Payment Methods: Supports LC, T/T, D/P, Western Union, and Money Gram.
Standard Packaging: Supplied in 25kg drums for safe transport.

Company profile

Wuhan Hanweishi Pharmchem Co., Ltd.
High Repeat Buyers ChoiceYears of Export ExperienceExperienced TeamExhibition Experience
Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2013-07-12Nearest Port: QINGDAO, SHENZHEN, ShanghaiAverage Response Time: ≤11.07hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB, CFR, CIF, CIP, CPT

AI-Powered supplier vetting

SummaryWuhan Hanweishi Pharmchem Co., Ltd. is a China-based limited company described as both a trading company and manufacturer/factory, with nine employees and a broad pharmaceutical, chemical, supplement, and related product scope. It has inventory capability, export experience of 10 years, and reports that 90% of total sales are exports. The supplier accepts FOB, CIF, and CFR quotation terms and has participated in CPHI China 2023. Its service infrastructure is limited: it has no overseas warehouse, showroom, agent, or branch, and offers services in zero countries according to the provided data. R&D and innovation evidence is weak, with no new products launched in the past year, no SDK, no 3D software design service, and only minor customization, although ODM service is available. No certification information, customer cases, or sufficient financial assessment evidence is provided.
Supplier typeThe supplier is identified as a limited company and is described as both a trading company and manufacturer/factory, while another record classifies it as a trading company. Its stated scope includes import, export, and agency activities, indicating a trading-led business with manufacturing/factory capability also reported.
After-Sales capabilityThe supplier reports inventory capability and has participated in an offline trade show, but it has no overseas warehouse, showroom, agent, or branch, and the overseas service-country count is stated as zero. Service governance is also weak because no written service-assessment or corrective/preventive-action procedures or records were provided.
R&D capabilityInnovation evidence is limited: no new products were launched in the past year, there is no SDK, no 3D software design service, and the supplier is not identified as a professional technical supplier. ODM service is available, but the overall evidence does not demonstrate strong ongoing innovation.
Customization capabilityThe supplier offers minor customization and ODM services. These explicit services demonstrate some customization capability, but the stated level is limited and does not indicate extensive or advanced customization.

Send Inquiry

*To:Wuhan Hanweishi Pharmchem Co., Ltd.Wuhan Hanweishi Pharmchem Co., Ltd.
*Content:
0/4000

Supplier replies will be sent to your registered email

You may also like